Replies to post #137384 on Biotech Values

[oc631]

This is intended to be a replication of BMY's 'wager'. And BMY didn't offer INHX a contingent 'Well, we'll pay you $2.5B if it passes safety hurdles'.

Are you assuming, in the wager with Dew, approval of INX-189?